Merck Ignored Fosamax Femur Injury Warnings, Jury Told

Law360, New York (April 9, 2013, 8:25 PM EDT) -- Merck & Co. on Tuesday faced its first suit claiming femur fractures were caused by its bone drug Fosamax in New Jersey federal court, with attorneys for a New York woman who sustained a femur break saying Merck ignored warnings of the drug’s risks.

In opening statements, attorneys for Bernadette Glynn told an eight-member jury that the evidence would prove the 58-year-old Glynn broke her right femur as a result of taking Fosamax to increase her bone density. Glynn’s is the first case to go to...
To view the full article, register now.